Screening and management of familial colon cancer

Genetic Predisposition to Cancer, Second Edition

Volumn , Issue , 2003, Pages 331-338

  Hodgson, Shirley V ^a   Murday, Victoria A ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40049105131     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (89)

1. Cannon-Albright L, Thomas T, Bishop D, et al. Characteristics of familial colon cancer in a large population base. Cancer 1989; 64:1971-1975.
2. Guillem JG, Forde KA, Treat MR, et al. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Dis Colon Rectum 1992; 35:523-529.
3. Rozen P, Fireman Z, Figer A, et al. Family history of colorectal cancer as a marker of potential malignancy within a screening programme. Cancer 1987; 60:248-254.
4. Anderson D, Strong L. Genetics of gastrointestinal tumours. Proceedings of the XIth International Cancer Conference. Excerpta Med 1974; 351:267-271.
5. Fuchs CS, Giovannucci EL, Colditz GA, et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994; 331:1669-1674.
6. Luchtefeld M, Syverson D, Solfelt M, et al. Is colonoscopic screening appropriate in asymptomatic patients with family history of colon cancer? Dis Colon Rectum 1991; 34:763-768.
7. Houlston RS, Murday V, Haracopos C, et al. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. Published erratum appears in Br Med J 1990; 301:446.
8. Houlston RS, Murday V, Haracopos C, et al. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. Br Med J 1990; 301:366-368.
9. Odes HS, Rozen P, Ron E, et al. Screening for colorectal neoplasia: A multi-centre study in Israel (see comments). Israel J Med Sci 1992; 28:21-38.
10. Stephenson B, Murday V, Finan P, et al. Feasibility of familybased screening for colorectal neoplasia experience in one general surgical practice. Gut 1993; 34:96-100.
11. Ford D, Easton E, Bishop DT, et al. Breast Cancer Consortium. Risks of cancer in BRCA-1 mutation carriers. Lancet 1994; 343:692-695.
12. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-1408.
13. Woolf CM. A genetic study of carcinoma of the large intestine. Am J Hum Genet 1958; 10:42-47.
14. Macklin MT. Inheritance of cancer of the stomach and large intestine in man. J Natl Cancer Inst 1960; 24:551-557.
15. Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976; 63:13-18.
16. Maire P, Morichau-Beauchant M, Drucker J, et al. Familial occurrence of cancer of the colon and the rectum: results of a 3-year case-control survey. Gastroenterologie clin biol 1984; 8:22-27.
17. Rozen P, Ron E, Fireman Z, et al. The relative value of faecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia. Cancer 1987; 60:2553-2558.
18. Bonelli L, Martines H, Conio M, et al. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case control study. Int J Cancer 1988; 41:513-517.
19. Kune GA, Kune S, Watson LF. The role of heredity in the aetiology of large bowel cancer: data from the Melbourne Colorectal Cancer Study. World J Surg 1989; 13:124-129; discussion 129-131.
20. Ponz de Leon M, Sassatelli R, Sacchetti C, et al. Familial aggregation of tumours in the 3-year experience of a population-based colorectal cancer registry. Cancer Res 1989; 49:4344-4348.
21. Stephenson BM, Finan PJ, Gascoyne J, et al. Frequency of familial colorectal cancer. Br J Surg 1991; 78:1162-1166.
22. Boutron MC, Faivre J, Quipourt V, et al. Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: A case control study. Gut 1995; 37:830-834.
23. St John D, McDermott F, Hopper J, et al. Cancer risk in the relatives of patients with common colorectal cancer. Ann Intern Med 1993; 118:785-790.
24. Rozen P, Fireman Z. Figer A, Ron E. Colorectal tumour screening in women with a past history of breast, uterine, or ovarian malignancies. Cancer 1986; 57:1235-1239.
25. Hardcastle J, Robinson M, Mulrow CD, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996; 348:1472-1477.
26. Kronberg O, Olsen J, Jorgensen O, Sondergaard O. Randomised study of screening for colon cancer with faecal-occult blood test. Lancet 1996; 348:1467-1471.
27. Burke W, Petersen G, Lynch P, et al. Recommendations for following care of individuals with an inherited predisposition to cancer in HNPCC. JAMA 1997; 277:915-919.
28. Mecklin JP, Jarvinen J. Treatment and follow-up strategies in HNPCC. Dis Colon Rectum 1993; 36:927-929.
29. Lynch HT, Harris RE, Lynch PM, et al. Role of heredity in multiple primary cancer. Cancer 1977; 40:1849-1854.
30. Levin TR, Palitz A, Grossman S, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA 1999; 281:1611-1617.
31. Dinning L, Hixson L, Clark L. Prevalence of distal colonic neoplasia associated with proximal colon cancers. Arch Intern Med 1994; 154:853-856.
32. Selby JV, Friedman GD, Queensbury CP, Weiss NS. A casecontrol study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326:653-657.
33. Muto T, Bussey H, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36:2251-2270.
34. Muller A, Sonnerberg A. Protection by endoscopy against death from colorectal cancer. Arch Intern Med 1995; 155:1741-1748.
35. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy: The National Polyp Study Workgroup. New Engl J Med 1993; 329:1977-1981.
36. Brewer D, Fung C, Chapuis P, Bokey E. Should relatives of patients with colorectal cancer be screened. Dis Colon Rectum 1994; 37:1328-1338.
37. Winawer SJ, Zauber AG, O’Brien MJ, et al. Randomised comparison of surveillance intervals after colonoscopic polypectomy. N Engl J Med 1993; 329:901-906.
38. Vasen HFA, Mecklin JP, Meera Khan P, Lynch HT. HNPCC. Lancet 1991; 338:877.
39. Aarnio M, Mecklin JP, Aaltonen LA, et al. Life-time risk of different cancers in HNPCC syndrome. Int J Cancer 1995; 64:430-433.
40. Lynch HT, Smyrk TC. HNPCC (Lynch Syndrome): An updated review. Cancer 1996; 78:1149-1167.
41. Mecklin JP, Jarvinen JJ. Clinical features of colorectal carcinoma in cancer family syndrome. Dis Colon Rectum 1986; 78:160-164.
42. Marra G, Boland CR. HNPCC. J Natl Cancer Inst 1995; 87:1114-1125.
43. Jarvinen JG, Mecklin JP, Sistonen P. Screening reduced colorectal cancer rate in families with HNPCC. Gastroenterology 1995; 108:1405-1411.
44. Ahlquist DA. Aggressive polyps in HNPCC: targets for screening. Gastroenterology 1995; 108:1590-1592.
45. Vasen HFA, Nagengast FM, Meera Khan P. Interval cancers in HNPCC (Lynch Syndrome). Lancet 1995; 345:1183-1184.
46. Vasen HFA, Watson P, Mecklin J-P, Lynch HT. ICG-HNPCC. New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch Syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 1999; 116:1453-1456.
47. Rodriguez-Bigas MA, Bolan CR, Hamilton SR, et al. A national Cancer Institute workshop on hereditary non-polyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89:1758-1761.
48. Viel A, Novella E, Gennard M, et al. Lack of PMS2-truncating mutations in patients with hereditary colorectal cancer. Int J Onc 1998; 13:565-569.
49. Lin HH, Chen CD, Chen CK, et al. Is total abdominal hysterectomy with bilateral salpingo-oophorectomy adequate for new FIGO stage 1 endometrial carcinoma? Br J Obstet Gynaecol 1995; 102:148-152.
50. Liu B, Parsons RE, Hamilton SR, et al. MSH2 mutations in HNPCC kindreds. Cancer Res 1994; 54:4590-4594.
51. Liu B, Parsons RE, Papadopoulos N, et al. Analysis of mismatch repair genes in HNPCC patients. Nature Med 1994; 2:169-174.
52. Farrington S, Lin-Goeike J, Long J, et al. Systematic analysis of MSH2 and MLH1 in young colon cancer patients and controls. Am J Hum Genet 1998; 63:749-759.
53. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of interational criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58:5248-5257.
54. de Leeuw WJ, Dierssan J, Vasen HF, et al. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol 2000; 192:328-335.
55. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumour spectrum, and pathology of HNPCC: An updated review. Gastroenterology 1993; 104:1535-1549.
56. Wijnen JT, Vasen HFA, Meera-Khan P, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998; 339:511-518.
57. Jass JR. Pathology of hereditary nonpolyposis colorectal cancer. Ann N Y Acad Sci 2000; 910:62-74.
58. Wijnen J, Khan P, Vasen H, et al. Hereditary non-polyposis colorectal cancer families not complying with the Amsterdam criteria show low frequency of mismatch-repair gene mutations. Am J Hum Genet 1997; 61:329-335.
59. Fitzgibbons RJ, Lynch HT, Lanspa SJ, et al. Surgical strategies for management of the Lynch syndromes. Hered Colorectal Cancer 1990; 211-217.
60. Lynch HT, Lynch JF. Genetics of colonic cancer. Digestion 1998; 59:481-492.
61. Jass JR, Stewart SM, Schroeder D, Lane MR. Eur J Gastroenterol Hepatol 1992; 4:523-527.
62. Warner EA, Parson AK. Screening and early diagnosis of gynaecologic cancers. Med Clin North Am 1996; 80:45-61.
63. Vasen HF, Watson P, Mecklin JP, et al. The epidemiology of endometrial cancer in hereditary non-polyposis colorectal cancer. Anticancer Res 1994; 14:1675-1678.
64. Osmers RGW, Kuhn W. Vaginosonography for early detection of endometrial carcinoma? Curr Opin Obstet Gynaecol 1990; 6:75-79.
65. Van den Bosch T, Van den Dael A. Combining vaginal ultrasonography and office endometrial sampling in the diagnosis of endometrial disease in postmenopausal women. Obstet Gynaecol 1995; 85:349-352.
66. Weber T. Clinical surveillance recommendations adopted for HNPCC. Lancet 1996; 348:465.
67. Michie S, Marteau T, On behalf of the FAP collaborative research group. Predictive genetic testing in children and adults: A study of emotional impact. British Human Genetics Conference, York, September 2000.
68. Giardello FM, Offerhaus JG. Phenotype and cancer risk of various polyposis syndromes. Eur J Cancer 1995; 31A:1085-1087.
69. Tytgat GNJ. Surveillance of familial adenomatous polyposis after ileorectal anastomosis or ileoanal pouch anastamosis. Gastrointest Endosc Clin North Am 1997; 7:111-127.
70. Fenton PA, Clarke SEM, Owen W, et al. Cribriform variant papillary thyroid cancer, a characteristic of familial adenomatous polyposis. Thyroid 2001; 11:193-197.
71. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: An attenuated form of familial polyposis. Cell 1993; 75: 951-957.
72. Laken SJ, Peterson GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet 1997; 17:79-83.
73. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classical adenomatous polyposis and germline mutations in MYH. NEJM 2003; 348:791-799.
74. Al-Tassan N, Chinnel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C>T:A mutations in colorectal tumours. Nat Genet 2002; 30:227-232.
75. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot syndrome. N Engl J Med 1995; 332:839-847.
76. Flanders T, Foulkes W. Cancers of the digestive system. In: Foulkes WD, Hodgson SV (eds.) Inherited susceptibility to cancer: Clinical, predictive and ethical perspectives. Cambridge: Cambridge University Press, 1998: Chapter 9.
77. Desai DC, Neale KF, Talbot IC, et al. Juvenile polyposis. Br J Surg 1995; 82:14-17.
78. Jass JR, Williams CB, Bussey HJ, Morson BC. Juvenile polyposis-a precarious condition. Histopathology 1988; 13:619-630.
79. Houlston R, Bevon R, Williams A, et al. Mutations in DPC4/SMAD4 cause juvenile polyposis syndrome but only in a minority of cases. Hum Molec Genet 1998; 7:1907-1912.
80. Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998; 280:1086-1088.
81. Zhou XP, Woodford-Richens K, Lehtonen R, et al. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 2001; 69:704-711.
82. Eng C, Peackocke M. PTEN and inherited hamartoma-cancer syndromes. Nature Genet 1998; 19:223.
83. Spigelman AD, Murday V, Phillips RK. Cancer and the Peutz-Jeghers Syndrome. Gut 1989; 11:1588-1590.
84. Konishi F, Wyse NE, Muto T, et al. Peutz-Jeghers polyposis associated with carcinoma of the digestive organs. Report of three cases and review of the literature. Dis-Colon Rectum 1987; 10:790-799.
85. Rashid A, Houlihan PS, Booker S, et al. Phenotype and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000; 119:323-332.
86. Hemminki A, Markie D, Tomlinson I, et al. A serine/threanine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391:184-187.
87. Gupta RA, DuBois RN, Wallace MC. New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity. Best Pract Clin Gastroenterol 2002; 16:945-956.
88. Huls G, Koornstra JJ, Kleibeuker JH. Non-steroidal antiinflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 2003; 362:230-232.
89. Viner JL, Umar A, Hawk EZ. Chemoprevention of colorectal cancer: Problems, progress and pospects. Gastroenterol Clinics of North America 2002; 31:971-979.